China’s Bribery Culture Poses Risks for Multinationals
This article is for subscribers only.
To the risks of doing business in China -- an authoritarian government, sprawling market, worsening pollution -- add another one: running afoul of local and U.S. anti-corruption laws.
Multinational companies are working to navigate bribery risks in China, where possible corruption by JPMorgan Chase & Co., GlaxoSmithKline Plc and Avon Products Inc. have sparked probes by the U.S. or Chinese authorities.